|Reproductive and Developmental Medicine|
The department has 10 research groups covering a wide range of pediatric disorders.
Immunology Group deals with immunodeficiency, allergy and collagen diseases. The group is renowned for the first successful human gene therapy in Japan.
Infectious Disease Group is well known for research in virology, including human metapneumovirus and human bocavirus.
Endocrinology Group is working on all aspects of pediatric endocrine disorders including growth problems, abnormal puberty, and diabetes mellitus.
Nephrology Group provides total care for patients with renal disorders including congenital anomalies, nephrotic syndrome, and renal failure.
Cardiology Group offers diagnosis and treatment for pediatric cardiac disorders including congenital heart disease, arrhythmia, and Kawasaki disease.
Hematology and Oncology Group functions as a center for diagnosis and treatment of patients with pediatric malignancy including leukemia/lymphoma and solid tumors, offering highly sophisticated blood stem cell transplantation.
Neurology Group takes care of patients with neurological disorders including developmental delay, epilepsy and muscular dystrophy. Neonatology Group offers intensive care for any problems of neonates including immature babies, congenital anomalies, and infection.
Medical Genetics and Dysmorphology Group offers diagnosis, management and genetic counseling for patients with genetic disorders.
Metabolic Disease Group deals with patients with congenital metabolic disorders and diseases in digestive system.
We provide the best education for medical students. Our education program for undergraduate students features systematic lectures and clinical clerkship. Specialists covering every field of pediatrics provide an excellent opportunity to recognize the wide spectrum of clinical pediatrics.
Graduate students can work on a wide variety of research activities. Combination of clinical and research opportunity would promise a successful career not only in pediatrics but in basic science.
We offer the integrated 3-year Residency Program. The goal of the program is to obtain the board certification of pediatrics. The Program is supported by a collaborative effort with the University Hospital and related institutions in Hokkaido. Under this program, the core of general pediatrics training will be provided through the extensive clinical experience in these institutions.
1. Ariga T: International Symposium: Gene Therapy Clinical Trials from Around the Globe, Hematopoietic stem cell gene therapy for two patients with adenosine deaminase (ADA) deficiency without myelopreparative conditioning; a suggestion for the optimal protocol for HSC gene therapy for ADA deficiency. The 10th Annual Meeting of American Society of Gene Therapy, Seattle (USA), 2007
2. Ariga T: Hematopoietic stem cell (HCS) gene therapy for two patients with adenosine deaminase (ADA) deficiency without cytoreductive conditioning; a suggestion for the optimal protocol for HSC gene therapy for ADA deficiency. Symposium VI Immune deficiency syndromes. The IVth Conference on Stem Cell Gene Therapy, Halkidiki, Thessaloniki, Greece, 2007
3. Shiraishi H: Graded magnetoencephalographic analysis for patients with epilepsy - For the global application for every patient with epilepsy -. Matsushima, Japan, 2007
Copyright © Hokkaido University Graduate School of Medicine / School of Medicine.